TNFRSF17 and Miyoshi myopathy: We detected BCMA expression in the 3 MM cell lines MM1.S (96.6% cells were BCMA+), OPM2 (91.3% cells were BCMA+), and H929 (99.5% cells were BCMA+) (Figure 2A).